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Sleep-Disordered Breathing in Acute Ischemic Stroke: A Mechanistic
Link to Peripheral Endothelial Dysfunction
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Background-—Sleep-disordered breathing (SDB) after acute ischemic stroke is frequent and may be linked to stroke-induced
autonomic imbalance. In the present study, the interaction between SDB and peripheral endothelial dysfunction (ED) was
investigated in patients with acute ischemic stroke and at 1-year follow-up.
Methods and Results-—SDB was assessed by transthoracic impedance records in 101 patients with acute ischemic stroke (mean
age, 69 years; 61% men; median National Institutes of Health Stroke Scale, 4) while being on the stroke unit. SDB was deﬁned by
apnea-hypopnea index ≥5 episodes per hour. Peripheral endothelial function was assessed using peripheral arterial tonometry
(EndoPAT-2000). ED was deﬁned by reactive hyperemia index ≤1.8. Forty-one stroke patients underwent 1-year follow-up
(39024 days) after stroke. SDB was observed in 57% patients with acute ischemic stroke. Compared with patients without SDB,
ED was more prevalent in patients with SDB (32% versus 64%; P<0.01). After adjustment for multiple confounders, presence of
SDB remained independently associated with ED (odds ratio, 3.1; [95% conﬁdence interval, 1.2–7.9]; P<0.05). After 1 year, the
prevalence of SDB decreased from 59% to 15% (P<0.001). Interestingly, peripheral endothelial function improved in stroke patients
with normalized SDB, compared with patients with persisting SDB (P<0.05).
Conclusions-—SDB was present in more than half of all patients with acute ischemic stroke and was independently associated with
peripheral ED. Normalized ED in patients with normalized breathing pattern 1 year after stroke suggests a mechanistic link
between SDB and ED.
Clinical Trial Registration-—URL: https://drks-neu.uniklinik-freiburg.de. Unique identiﬁer: DRKS00000514. ( J Am Heart Assoc.
2017;6:e006010. DOI: 10.1161/JAHA.117.006010.)
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S leep-disordered breathing (SDB), including obstructivesleep apnea and central sleep apnea, is frequently
observed in patients with cardiovascular diseases or stroke.1
SDB is characterized by periodic breathing frequency and
depth. The prolonged episodes of breathing cessation lead to
hypoxia, hypercapnia, and sympathetic activation, subse-
quently increasing the risk for cardiovascular events.2 Several
clinical studies observed an association of obstructive sleep
apnea—caused by the collapse of upper airways—with
systemic inﬂammation, atrial ﬁbrillation, (recurrent) stroke,
and heart failure.3,4
Compared with wakefulness, natural sleep is associated
with increased carbon dioxide pressure in blood.5 After
cerebral stroke, an impaired sensitivity of the medullary
respiratory center to carbon dioxide leads to relative hyper-
ventilation and subsequent to hypocapnia.6 Therefore, noc-
turnal as well as diurnal periodic breathing (eg, Cheyne–Stoke
respiration) with episodes of hypoxia and hypercapnia might
serve as a compensatory mechanism for normalization of
carbon dioxide pressure.7 Indeed, nocturnal hypocapnia was
independently associated with Cheyne–Stoke respiration after
stroke.6 In addition, input from the cerebral cortex has been
suggested as a suppresser of periodic pathological breathing
patterns, generated in the brainstem. Therefore, the loss of
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the cortical control on the brainstem after brain injury might
be causal for central sleep apnea.
SDB is accompanied by increased sympathetic activation.
The most common manifestations of autonomic dysfunction
observed in association with acute stroke are cardiac
arrhythmias, changes of heart rate variability, ﬂuctuations of
blood pressure, endothelial dysfunction (ED), and myocardial
injury.8–12 Previously, we reported the presence of peripheral
ED in patients with acute ischemic stroke.13 However, only a
few studies investigated an association between SDB and ED
in stroke.14,15
We hypothesized that nocturnal SDB after acute ischemic
stroke may contribute to development of peripheral ED.
Subsequently, we prospectively examined patients in the
acute phase after ischemic stroke and 1 year afterward.
Patients and Methods
The Study Protocol
The present analysis is a part of the prospective, single-
center observational BoSSS (Body Size in Stroke Study;
German registry for clinical trials number DRKS00000514),
performed at the stroke unit (Charite–Medical School, Berlin,
Germany).
One hundred one consecutive patients (aged 35–89 years)
with acute ischemic stroke of the middle cerebral artery
territory were recruited to this study within 48 hours after
symptom onset. In the acute phase after stroke, patients were
treated according to the current guidelines recommendations
individually adjusted (including antiplatelet drugs, statins,
angiotensin-converting enzyme inhibitors, and b-blocker).
Thirty-one patients (31%) received thrombolytic therapy
(Actilyse; Boehringer Ingelheim, Ingelheim am Rhein, Ger-
many) according to the appropriate therapeutic window.
The study protocol has been published previously.16
Brieﬂy, inclusion criteria were: age ≥21 years; presence of
acute ischemic stroke within the middle cerebral artery
territory; and neurological deﬁcit according to the National
Institutes of Health Stroke Scale (NIHSS) ≤12. Exclusion
criteria were acute and chronic inﬂammatory diseases,
immune suppressive therapy, history of cancer shorter than
5 years, and women with known pregnancy.
The protocol was approved by the Charite Ethics Committee,
and written informed consent was obtained from all subjects.
Baseline Examinations
Baseline examinations were completed in-hospital in the
acute phase after stroke. Stroke-related neurological deﬁcit
was evaluated by the NIHSS and estimation of ischemic brain
injury volume was assessed using the Alberta Stroke Program
Early CT score.17 Functional impairment and disability were
evaluated by the modiﬁed Rankin Scale (mRS) and the Barthel
Index (BI). Venous blood samples were obtained under
standardized conditions after overnight fasting. Standard
biochemical parameters were assessed immediately in the
routine clinical laboratory. Body mass index was calculated as
a ratio of body weight and squared height (kg/m²).
Assessment of SDB
Screening for SDB was performed 42 days after symptom
onset using transthoracic impedance recording integrated
into a Holter system (CardioDay; Getemed, Teltow, Germany).
Analyses of SDB were performed visually as previously
described.18 Presence of SDB was deﬁned by apnea-
hypopnea index (AHI) ≥5 episodes per hour.19
Peripheral endothelial function
Quantitative determination of peripheral endothelial function
was assessed by application of ﬁnger plethysmograph
(EndoPAT2000; Itamar Medical, Caesarea, Israel) as described
previously.13 Assessments were performed 42 days after
symptom onset under standardized conditions after at least
15 minutes of supine rest in a quiet, air-conditioned room. An
estimation of endothelial function was based on peripheral
arterial tonometry of the index ﬁnger of the nonparetic arm. A
reactive hyperemia index (RHI) was deﬁned as a ratio between
the post- and preoccluded measurement of the peripheral
arterial tonometry signal corrected for signal of the nonoc-
cluded contralateral to the brain lesion arm. ED was
considered with RHI ≤1.8.
Clinical Perspective
What Is New?
• Our observational study demonstrates an association of
peripheral endothelial dysfunction with sleep-disordered
breathing in patients with acute ischemic stroke.
• Normalization of sleep-disordered breathing pattern 1 year
after stroke was associated with improved endothelial
function.
What Are the Clinical Implications?
• Whereas sleep-disordered breathing is a frequent ﬁnding in
the acute phase of stroke, our study suggests a transient
character of SDB in the majority of stroke patients with
mild-to-moderate neurological deﬁcit on admission.
• Large, prospective stroke studies including a systematic
screening for sleep-disordered breathing and endothelial
dysfunction are needed to assess an impact on the frequency
of cerebrovascular and cardiovascular complications.
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Echocardiographic evaluation of myocardial morphology and
global left ventricular function was performed (Vivid S5 with
3S-RS 1.5–3.6 MHz transducer; GE Medical Systems, Marl-
borough, MA). Left ventricular ejection fraction (LVEF) was
calculated according to the Simpson biplane method. Left
ventricular diastolic dysfunction was determined according to
the diagnostic criteria of the European Society of Cardiology:
septal (<7 cm/s) or lateral (<10 cm/s) mitral annular early-
diastolic (e0) peak velocity by pulsed-waved spectral tissue
Doppler imaging and LVEF 50% to 55%.20 Left ventricular
systolic dysfunction was considered in patients with clinical
sings of heart failure (HF) and LVEF ≤50%. Patients with
normal LVEF (≥55%) and without clinical signs of HF were
considered to have no HF.
One Year Follow-up
Repeated measurements of the baseline study examinations
were conducted in 41 patients at 1-year follow-up (FU). Sixty
patients were lost to FU.
Statistical Analysis
All data were presented as means SD, median (interquartile
range; IQR) or percentage, as appropriate. Data were tested
for normal distribution using the Kolmogorov–Smirnov test.
Statistical comparisons were made using paired or unpaired
Student t tests or Mann–Whitney U test or Kruskal–Wallis
test. The chi-squared test was used to assess categorical
distribution between groups. Simple linear regression and
Pearson correlation and uni- and multivariate logistic regres-
sion analyses were used, as appropriate. A P<0.05 was
considered statistically signiﬁcant. Statistical analyses were
performed with the StatView software package (version 5.0;
SAS Institute Inc, Cary, NC).
Results
One-hundred one patients with acute ischemic stroke
(6912 years; body mass index, 28.24.6 kg/m2) were
studied within 42 days after symptom onset. The study
cohort consisted of 62 (61%) male and 39 female patients.
Patients were mild to moderate disabled (median NIHSS, 4.0
[IQR, 2–7]; mean BI, 7133; mean mRS, 2.31.5; Table 1).
Median AHI in the entire study cohort was 5.7 [IQR, 3–13]
episodes per hour. Baseline characteristics of all patients are
given in Table 1.
Patients were divided according to the presence or
absence of SDB. In 58 patients (57%), the presence of SDB
was identiﬁed (median AHI, 11.6 [IQR, 7–18.25] episodes
per hour). This subgroup consisted mainly of male patients
(72%). Compared with patients without SDB, patients with
SDB had more-severe neurological deﬁcit according to the
NIHSS (Figure 1A), larger infarct volume in approximation
by Alberta Stroke Program Early CT score (Figure 1B), as
well as higher functional impairment according to the mRS
and BI (Figure 1C and 1D; Table 1). No further differences
were observed regarding comorbidities or clinical and
biochemical characteristics between both of the subgroups
(Table 1).
Peripheral Endothelial Function in Relation to
SDB After Acute Ischemic Stroke
Patients with SDB showed peripheral ED—as indicated by RHI
—compared with patients without SDB (RHI 1.70.5 versus
2.00.4; P=0.001; Figure 2A). Peripheral ED was present in
64% of patients with SDB and in 32% of patients without SDB
(P=0.003). ED was strongly associated with higher AHI in
simple regression analysis (r=0.38; P<0.001; Figure 2B). In
univariate logistic regression, presence of SDB was associ-
ated with presence of peripheral ED (odds ratio [OR], 3.9 [95%
conﬁdential interval {CI}, 1.6–9.4]; P=0.003; Table 2). After
adjustment for sex, age, and body mass index, the presence
of SDB remained independently associated with the presence
of ED (OR, 3.1 [CI, 1.2–7.9]; P<0.05).
Logistic Regression Analyses
In univariate logistic regression an association between the
presence of SDB and neurological deﬁcit according to the
NIHSS (OR, 1.2 [95% CI, 1.1–1.4]; P<0.01), functional
impairment according to the mRS (OR, 1.7 [95% CI, 1.2–
2.3]; P<0.001) or to the BI (OR, 0.9 [95% CI 0.8–1.0]; P<0.05),
and male sex (OR, 3.0 [95% CI, 1.3–6.9]; P=0.01) was found at
baseline (Table 2). The stroke affected hemisphere, atrial
ﬁbrillation, and cardiac function (E/e0 ratio or LVEF) were not
correlated with presence of SDB in the acute phase after
ischemic stroke (Table 2).
Cardiac Function and SDB in Acute Stroke
Basic echocardiographic parameters were similar in patients
with or without SDB (Table 3). Comparing stroke patients
without HF (n=21) with patients with Left ventricular
diastolic dysfunction (n=62) or those with left ventricular
systolic dysfunction (n=18) revealed higher AHI in patients
with left ventricular systolic dysfunction (P=0.04; Figure 3).
No signiﬁcant difference in SDB prevalence was
observed between these groups (no HF, 43%; left ventric-
ular diastolic dysfunction, 58%; left ventricular systolic
dysfunction, 72%).
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SDB and Endothelial Function 1 Year After
Ischemic Stroke
Clinical characteristics of 41 patients who were available at
1-year FU are given in Table 4. One year after stroke, 19
patients (46%) improved signiﬁcantly their functional capacity
according to the BI (delta BI, 2721; P<0.001) compared to
baseline, 18 (44%) remained unchanged, whereas 4 worsened
their functional capacity (delta BI, 1913; P=0.058).
Furthermore, 63% of the patients revealed a body weight
increase compared to baseline (delta body weight
6.25.6 kg; P=0.002), whereas 37% showed a body
weight lost (delta body weight, 3.73.8 kg; P<0.0001).
Prevalence of SDB decreased from 59% at baseline to 15% at
Table 1. Baseline Characteristics of Study Population




SDB (N=58) P Values
Age, y 6912 6813 6911 0.7
Male sex, % 61 47 72 0.008
BMI, kg/m2 28.24.6 28.75.7 27.83.5 0.3
Diastolic BP, mm Hg 8014 8115 7913 0.5
Systolic BP, mm Hg 14121 14224 14018 0.7
Thrombolytic therapy, % 31 23 21 (36) 0.2
AHI, episodes/h 5.7 [3–13] 2.5 [1–3] 11.6 [7–19] <0.0001
Stroke severity
ASPECT 8.41.4 8.91.1 8.11.6 0.007
NIHSS 4.0 [2–7] 3 [2–4] 5 [2.75–8] 0.01
NIHSS ≥5, % 41 23 53 0.002
Barthel Index 7133 8025 6437 0.014
Modified Rankin 2.31.5 1.81.1 2.81.6 <0.001
Right hemispheric stroke, % 55 49 61 0.3
Medical history
Atrial fibrillation, % 18 14 21 0.5
History of sleep apnea, % 2  3 
Hypertension, % 69 61 76 0.1
Diabetes mellitus, % 26 21 29 0.4
Dyslipidemia, % 33 33 33 0.9
Biochemistry
Hemoglobin, g/L 14.51.6 14.22.0 14.81.3 0.2
Glucose, mg/dL 11242 11547 10938 0.5
HbA1C, mg/dL 6.11.1 6.21.3 5.90.9 0.2
Sodium, mmol/L 140.63.5 140.13.9 141.13.2 0.2
Potassium, mmol/L 4.00.4 4.10.4 4.00.5 0.3
Triglyceride, mg/dL 13961 13862 13961 0.9
Cholesterol, mg/dL 18544 19146 17843 0.1
Low-density lipoprotein, mg/dL 10839 11337 10441 0.2
High-density lipoprotein, mg/dL 48.015.0 51.11 6.5 46.013.7 0.1
Creatinine, mg/dL 0.90.2 0.90.2 1.00.2 0.2
C-reactive protein, mg/dL 4.8 [2–8] 4.8 [2–8] 5.0 [2–9] 0.3
Uric acid, mg/dL 5.31.4 5.11.4 5.51.4 0.3
Values are meanSD, median [interquartile range], or percentage. AHI indicates Apnea-hypopnea index; ASPECT, Alberta Stroke Program Early CT; BMI, body mass index; BP, blood
pressure; HbA1C, hemoglobin A1C; NIHSS, National Institutes of Health Stroke Scale; SDB, sleep-disordered breathing.
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1 year follow-up (P<0.001). Median AHI decreased from 7.1
[IQR, 3–13.75] episodes per hour at baseline to 2.15 [2–3.75]
episodes per hour at 1-year FU (P<0.001). All 6 stroke
patients with sustained SDB had right hemispheric middle
cerebral artery stroke. Notably, only stroke patients with
normalized nocturnal breathing pattern compared with base-
line showed improved peripheral endothelial function after
1 year (RHI, 2.00.6 versus 1.70.3 at baseline, P=0.03,
respectively; Figure 4). By contrast, patients with sustained
SDB after 1 year still showed ED (RHI, 1.70.5 at FU versus
1.70.3 at baseline, P=0.9; Figure 4).
Discussion
The main ﬁndings of the present study are (1) the association
of peripheral ED with presence of SDB in patients with acute
stroke and (2) an improvement of peripheral endothelial
function in a subset of study patients with recovery of SDB
1 year after ischemic stroke. Furthermore, we conﬁrm earlier
studies showing that SDB is frequently found in patients with
acute ischemic stroke, particularly in those with moderate
neurological deﬁcit.
Inﬂuence of SDB on the Endothelial Function
We observed a strong association between presence of SDB
and peripheral ED in the acute phase after ischemic stroke.
Whereas ED belongs to established risk factors contributing
to the development of cerebrovascular and cardiovascular
diseases, ED was also found in around 30% of stroke patients
without SBD in the acute phase after ischemic stroke.
Increased sympathetic activation after stroke might lead to
transient worsening of autonomic function.11 Our results
support this hypothesis by observing an improvement of
endothelial function in patients who recovered from SDB
1 year after the index stroke, but not in those patients with
persistent SDB. Our data support an association between the
SBD and ED, because the presence of SDB remained
independently associated with the peripheral ED (adjusted









































































D P < 0.05
Figure 1. Neurological deﬁcit at baseline according to the National Institutes of Health Stroke Scale
(NIHSS); (A); estimation of stroke-related brain lesion according to the Alberta Stroke Program Early CT
(ASPECT) score (B); functional impairment at baseline according to the modiﬁed Rankin scale (mRS) (C);
functional disability at baseline according to the Barthel index (D) in patients without sleep-disordered
breathing (SDB) compared with the patients with SDB.
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Peripheral vascular function has been analyzed in several
studies before. Peripheral arterial tonometry techniques—
based on the reactive hyperemia induced by forearm ischemia
—enables noninvasive measurements of the peripheral
endothelial function and correlates signiﬁcantly with ﬂow-
mediated dilation of the brachial artery.21 The measurement of
endothelial function in the current study was performed on the
index ﬁnger of the nonparetic arm. We therefore believe that
the ﬁndings represent a systemic effect on endothelial function
and are not biased by local effects of the paretic limb.
The association between ED and SDB has been shown in
few studies.22–24 However, a recent study stated an associ-
ation of moderate and severe SDB with increased arterial
stiffness in patients 3 months after stroke, but did not ﬁnd an
association with endothelial dysfunction.15 Because repeated
measurements in our study demonstrate a temporal course of
an association, the delayed follow-up in the recent study may
explain the respective ﬁndings. Our observations are in line
with previous reports showing a temporal imbalance of
autonomic nervous regulation that attenuates within days
after acute stroke.11 A recent meta-analysis demonstrated a
clinically relevant improvement of endothelial function after
treatment of OSA with continuous positive airway pressure,
which is also in accord with our ﬁndings.25
SDB and Autonomic Dysfunction
Consistent with previous studies,26,27 our study showed that
stroke patients with SDB had more often severe stroke
compared with those without SDB, whereas both patient
groups were comparable regarding demographic and comor-
bidity status as well as metabolic, cardiac, and inﬂammatory
characteristics. The association of SDB with neurological
impairment might be related to stroke-associated autonomic
vegetative imbalance. However, a previous study showed an
association between severe stroke and progressive failure of
cardiac autonomic function in 50 patients with ischemic
stroke.28 In our present study, the Alberta Stroke Program
Early CT score at baseline—as an estimation of stroke volume
—was associated with a higher prevalence of SDB. Further-
more, we observed an association between SDB and periph-
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A P < 0.01
Figure 2. Peripheral endothelial function accord-
ing to reactive hyperemia index (RHI) in patients
without sleep-disordered breathing (SDB) and in
those with SDB after acute ischemic stroke (A).
Association between the peripheral endothelial
function according to RHI and the severity of SDB
according to apnea-hypopnea index (AHI) (B).
Table 2. Logistic Regression Analyses Between Presence of
SDB and Clinical Variables
Parameter OR 95% CI P Value
Univariate analyses
Reactive hyperemia
index, per 0.1 point
0.15 0.05 to 0.51 0.002
Presence of endothelial
dysfunction
3.57 1.49 to 8.58 0.004
NIHSS, per point 1.19 1.05 to 1.36 0.009
NIHSS ≥5 3.79 1.58 to 9.10 0.003
Barthel index, per 10 points 0.88 0.78 to 0.99 0.046
Modified Rankin Scale, per point 1.66 1.22 to 2.26 0.001
ASPECT, per point 0.62 0.43 to 0.89 0.01
Male sex 3.02 1.32 to 6.93 0.009
Lesion of right hemisphere 1.48 0.67 to 3.28 0.33
Atrial fibrillation 1.61 0.55 to 4.70 0.38
LVEF, per 5% 0.89 0.69 to 1.13 0.33
E/e0 ratio 1.00 0.92 to 1.09 0.92
Multivariate analyses (adjusted for age, sex, BMI)
1. Reactive hyperemia index 0.17 0.05 to 0.60 0.006
2. Presence of endothelial
dysfunction
3.09 1.21 to 7.87 0.018
3. Presence of endothelial
dysfunction and NIHSS ≥5
17.6 2.18 to 142.3 0.007
ASPECT indicates Alberta Stroke Program Early CT; BMI, body mass index; CI, conﬁdence
interval; LVEF, left ventricular ejection fraction; NIHSS, National Institutes of Health
Stroke Scale; OR, odds ratio; SDB, sleep-disordered breathing.
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Of note, other factors than impaired central control of
vegetative regulation may contribute to ED in acute stroke as
well. Previously, we have shown a role of the L-arginine/nitric
oxide pathway in the peripheral endothelial function in
patients with acute stroke, by observing elevated levels of
asymmetric dimethylarginine, an endogenous inhibitor of
nitric oxide synthesis, in parallel to stroke severity.13
SDB: A Potential Treatment Target After Stroke?
The question is whether patients should be treated for SDB in
the acute phase of stroke. Based on the observed association
in the present study, normalized breathing pattern may
attenuate autonomic nervous imbalance and may hence
prevent clinical complications such as arrhythmias, blood
pressure peaks, or ED. Given the transient character of this
neurovegetative imbalance, also, a temporary intervention
may be effective.11
In contrast to these considerations, however, recent data
put into question a potential beneﬁt from augmented








SDB (N=58) P Values
HR, bpm 7111 7212 0.9
LVEF, % 577 5610 0.3
LA diameter, mm 41.35.3 42.06.0 0.5
LV wall diastolic diameter, mm 11.12.3 11.52.2 0.5
LV diastolic diameter, mm 47.38.3 48.36.9 0.5
IVS diastolic diameter, mm 12.42.4 13.12.4 0.1
Septal e0 mitral annular
velocity by TDI, cm/s
7.02.7 6.52.6 0.5
Lateral e0 mitral annular
velocity by TDI, cm/s
8.93.2 7.42.6 0.1
E/e0 ratio 115 125 0.9
RA diameter, mm 38.07.5 35.48.4 0.3
RV diastolic diameter, mm 2.90.7 3.51.7 0.3
TAPSE, mm 236 225 0.3
Values are meanstandard deviation. bpm indicates beats per minute; HR, heart rate;
IVS, intraventricular septum; LA, left atrial; LV, left ventricular; LVEF, left ventricular
ejection fraction; RA, right atrial; RV, right ventricular; SDB, sleep-disordered breathing;



























No HF LVDD LVSD
P < 0.05
Figure 3. Severity of sleep-disordered breathing
(SDB) according to apnea-hypopnea index (AHI) in
patients without heart failure (HF), in those with left
ventricular diastolic dysfunction (LVDD) and in
those with left ventricular systolic dysfunction
(LVSD).
Table 4. Clinical Characteristics of Patients Completed




FU (N=41) P Values
Age, y 6812 6911 <0.001
BMI, kg/m² 27.64.0 28.54.5 0.03
Male sex, n (%) 28 (70) 28 (70) 
Days after stroke 32 39024 <0.001
Thrombolytic therapy, n (%) 11 (27)  
Presence of SDB, n (%) 24 (58.5) 6 (14.6) <0.001
AHI, episodes/h 7.0 [3–13] 2.15 [2–3.75] <0.001
RHI 1.80.4 1.90.5 0.2
Barthel Index 8027 9317 0.001
Modified Rankin Scale 2.01.2 1.31.1 <0.001
AHI indicates apnea-hypopnea index; BMI, body mass index; FU, follow-up; RHI, reactive
hyperemia index; SDB, sleep-disordered breathing.
Sustained SDB (N 6)
Normalized SDB (N 18)

























Figure 4. Peripheral endothelial function accord-
ing to reactive hyperemia index (RHI) in the follow-up
cohort at baseline and at 1-year follow-up examina-
tion. SDB indicates sleep-disordered breathing.
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ventilation support therapy in the SDB. Considering Cheyne–
Stoke respiration as a part of the compensatory mechanism in
autonomic dysfunction,6 manipulating this breathing pattern
could be detrimental. Indeed, a recent large, randomized
treatment trial (SERVE-HF [The Treatment of Predominant
Central Sleep Apnoea by Adaptive Servo Ventilation in
Patients With Heart Failure]) investigated the treatment of
the SBD by adaptive servoventilation in patients with chronic
HF with reduced ejection fraction showed an increased
mortality in the intervention group.29 The investigators
hypothesized that distraction from the compensatory breath-
ing pattern by the adaptive servo ventilation might be
responsible for the adverse outcome in the study.
Notably, all patients with sustained SDB at 1-year FU in the
present study suffered from a right hemispheric stroke. Both
hemispheres are known to have a different inﬂuence on
autonomic function, and increased sympathetic activity has
been observed in right hemispheric stroke in experimental
stroke models and in human stroke.30
There are some limitations of the present study. The study
population was limited to patients with mild-to-moderate
stroke. One could speculate that a more-pronounced mech-
anistic interaction may have been observed in patients with
even more-severe stroke. Indeed, we detected only a small
number of patients with severe SBD in this speciﬁc study
population. This makes the founded changes in ED more
remarkable. Furthermore, the detection of SDB was based on
1 parameter. The standard sleep apnea monitoring includes a
minimum of 3 parameters: airﬂow, respiratory effort, and
blood oxygenation.31 Impedance is a known technique for
detection of the thoracic effort, but does not allow distin-
guishing between central and obstructive breathing disorders.
Furthermore, the calculated AHI is an estimation because
sleep time was anamnestic collected. However, screening is
feasible and accurate.18,32 Another limitation was a small
number of patients available for FU assessment. One year
after stroke, all of the patients were contacted either by
telephone or by mail and invited to 1-year FU. As a result,
roughly 40% of the patients were able to come to the hospital.
The analyses of patients who came to 1-year FU in
comparison with the rest of the entire study cohort (age,
7012 years; body mass index, 28.64.9 kg/m2) revealed
better physical performance (BI, 8026 versus 6435;
P=0.016, and mRS, 2.01.2 versus 2.61.6; P=0.026,
respectively) at baseline. Thus, moderate functional impair-
ment and long-term disability might be causal for the high rate
of loss to FU in the present study.
Conclusions
This study explores an interaction between ischemic stroke,
SDB, and peripheral ED (Figure 5). This is an important
observation, which identiﬁes a modiﬁable risk factor, and even
a potential therapeutic target. Acute ischemic stroke is
accompanied by a high prevalence of SDB, probably attributed
to loss of cortical control and autonomic nervous system
Figure 5. Interaction between acute ischemic stroke, sleep-disordered breathing, and peripheral
endothelial dysfunction.
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imbalance. Whereas SDB was transient in a subset of stroke
patients, peripheral ED—as a surrogate marker of autonomic
dysfunction—was associated with the presence of SDB after
acute ischemic stroke and during the clinical course. Further
studies are needed to analyze an impact of SDB in patients
with ischemic stroke.
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